-
1
-
-
0031799666
-
A tale of novel intoxication: A review of the effects of gamma-hydroxybutyric acid with recommendations for management
-
Li J, Stokes SA, Woeckener A. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management. Ann Emerg Med 1998;31: 729-36.
-
(1998)
Ann Emerg Med
, vol.31
, pp. 729-736
-
-
Li, J.1
Stokes, S.A.2
Woeckener, A.3
-
2
-
-
0018176540
-
Improved pharmacological activity via pro-drug modification: Comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone
-
Lettieri J, Fung HL. Improved pharmacological activity via pro-drug modification: comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone. Res Commun Chem Pathol Pharmacol 1978;22:107-18.
-
(1978)
Res Commun Chem Pathol Pharmacol
, vol.22
, pp. 107-118
-
-
Lettieri, J.1
Fung, H.L.2
-
3
-
-
0024811044
-
Gammahydroxybutyrate: An endogenous regulator of energy metabolism
-
Mamelak M. Gammahydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci Biobehav Rev 1989;13:187-98.
-
(1989)
Neurosci Biobehav Rev
, vol.13
, pp. 187-198
-
-
Mamelak, M.1
-
4
-
-
0025716923
-
Multistate outbreak of poisonings associated with illicit use of gamma hydroxy butyrate
-
CDC. Multistate outbreak of poisonings associated with illicit use of gamma hydroxy butyrate. MMWR 1990;39:861-3.
-
(1990)
MMWR
, vol.39
, pp. 861-863
-
-
-
5
-
-
0031552175
-
Gamma hydroxy butyrate use - New York and Texas 1995-1996
-
CDC. Gamma hydroxy butyrate use - New York and Texas 1995-1996. MMWR 1997;46:281-3.
-
(1997)
MMWR
, vol.46
, pp. 281-283
-
-
-
6
-
-
0030742628
-
Gamma butyrolactone poisoning and its similarities to gamma hydroxybutyric acid: Two case reports
-
Rambourg-Schepens MO, Buffet M, Durak C, Mathieu-Nolf M. Gamma butyrolactone poisoning and its similarities to gamma hydroxybutyric acid: two case reports. Vet Hum Toxicol 1997;39:234-5.
-
(1997)
Vet Hum Toxicol
, vol.39
, pp. 234-235
-
-
Rambourg-Schepens, M.O.1
Buffet, M.2
Durak, C.3
Mathieu-Nolf, M.4
-
7
-
-
0032541575
-
Butyrolactone-induced central nervous system depression after ingestion of RenewTrient, a "dietary supplement"
-
LoVecchio F, Curry SC, Bagnasco T. Butyrolactone-induced central nervous system depression after ingestion of RenewTrient, a "dietary supplement" [Letter]. N Engl J Med 1998;339:847-8.
-
(1998)
N Engl J Med
, vol.339
, pp. 847-848
-
-
LoVecchio, F.1
Curry, S.C.2
Bagnasco, T.3
-
8
-
-
0031048527
-
Gamma-hydroxybutyrate: An emerging drug of abuse that causes physical dependence
-
Galloway GP, Frederick SL, Staggers FE, Gonzales M, Stalcup SA, Smith DE. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 1997;92:89-96.
-
(1997)
Addiction
, vol.92
, pp. 89-96
-
-
Galloway, G.P.1
Frederick, S.L.2
Staggers, F.E.3
Gonzales, M.4
Stalcup, S.A.5
Smith, D.E.6
-
9
-
-
0030199124
-
Coma and respiratory arrest after exposure to butyrolactone
-
Higgins TF, Borron SW. Coma and respiratory arrest after exposure to butyrolactone. J Emerg Med 1996;14:435-7.
-
(1996)
J Emerg Med
, vol.14
, pp. 435-437
-
-
Higgins, T.F.1
Borron, S.W.2
-
10
-
-
0003491354
-
-
Rockville, Maryland: US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Talk paper T99-5
-
Food and Drug Administration. FDA warns about products containing gamma butyrolactone or GBL and asks companies to issue a recall. Rockville, Maryland: US Department of Health and Human Services, Public Health Service, Food and Drug Administration, 1999. (Talk paper T99-5). Available at: 〈http://www.fda.gov/bbs/topics/ANSWERS/ANS00937.html〉. Accessed February 24, 1999.
-
(1999)
FDA Warns about Products Containing Gamma Butyrolactone or GBL and Asks Companies to Issue a Recall
-
-
|
